Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms

dc.contributor.authorSingh, Rajendra K.en
dc.contributor.authorPatel, Kapil D.en
dc.contributor.authorLeong, Kam W.en
dc.contributor.authorKim, Hae Wonen
dc.date.accessioned2025-03-20T08:33:43Z
dc.date.available2025-03-20T08:33:43Z
dc.date.issued2017-03-29en
dc.description.abstractTheranostics based on nanoparticles (NPs) is a promising paradigm in nanomedicine. Mesoporous silica nanoparticle (MSN)-based systems offer unique characteristics to enable multimodal imaging or simultaneous diagnosis and therapy. They include large surface area and volume, tunable pore size, functionalizable surface, and acceptable biological safety. Hybridization with other NPs and chemical modification can further potentiate the multifunctionality of MSN-based systems toward translation. Here, we update the recent progress on MSN-based systems for theranostic purposes. We discuss various synthetic approaches used to construct the theranostic platforms either via intrinsic chemistry or extrinsic combination. These include defect generation in the silica structure, encapsulation of diagnostic NPs within silica, their assembly on the silica surface, and direct conjugation of dye chemicals. Collectively, in vitro and in vivo results demonstrate that multimodal imaging capacities can be integrated with the therapeutic functions of these MSN systems for therapy. With further improvement in bioimaging sensitivity and targeting specificity, the multifunctional MSN-based theranostic systems will find many clinical applications in the near future.en
dc.description.sponsorshipThis research was supported by the Priority Research Centers Program (2009-0093829) and Global Research Laboratory Program (GRL; 2015032163) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education Science and Technology.en
dc.description.statustrueen
dc.format.extent29en
dc.identifier.otherScopus:85016642101en
dc.identifier.otherPubMed:28274115en
dc.identifier.urihttps://dspace-test.anu.edu.au/handle/1885/733723522
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85016642101&partnerID=8YFLogxKen
dc.language.isoEnglishen
dc.rightsPublisher Copyright: © 2017 American Chemical Society.en
dc.sourceACS Applied Materials and Interfacesen
dc.subjectextrinsic combinationen
dc.subjectintrinsic defecten
dc.subjectmesoporous silica nanoparticlesen
dc.subjectmultifunctionalen
dc.subjecttheranosticsen
dc.titleProgress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platformsen
dc.typeReview articleen
local.bibliographicCitation.lastpage10337en
local.bibliographicCitation.startpage10309en
local.contributor.affiliationSingh, Rajendra K.; Dankook Universityen
local.contributor.affiliationPatel, Kapil D.; Dankook Universityen
local.contributor.affiliationLeong, Kam W.; Dankook Universityen
local.contributor.affiliationKim, Hae Won; Dankook Universityen
local.identifier.citationvolume9en
local.identifier.doi10.1021/acsami.6b16505en
local.identifier.purecd640f89-7b96-4f0b-97ee-be4bb0052affen
local.type.statusPublisheden

Downloads